What Are the Requirements for Taking Ozempic?

Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic, was originally developed for type 2 diabetes but has become a leading medication for weight management based on clinical evidence showing 15–22% body weight reduction over 68 weeks. Understanding who qualifies for this treatment and what medical criteria apply helps you determine if semaglutide is right for your health goals.

Medical Eligibility Criteria for Semaglutide Treatment

Semaglutide candidates typically have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with weight-related health conditions such as hypertension, type 2 diabetes, or sleep apnea. A healthcare provider evaluates your medical history, current medications, and metabolic markers to confirm suitability. PlexusDx clinicians review each patient's baseline health data before starting any compounded semaglutide protocol.

Certain medical conditions may affect eligibility. Patients with a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, severe kidney or liver disease, or active pancreatitis require additional clinical assessment. Your PlexusDx provider performs a thorough evaluation to ensure safe treatment initiation and ongoing monitoring.

How BMI and Weight-Related Conditions Factor Into Approval

The FDA-approved labeling for semaglutide defines weight loss candidacy as a BMI ≥30 kg/m² or BMI ≥27 kg/m² with comorbid conditions. A BMI of 27 with obesity-related illness—including type 2 diabetes, cardiovascular disease, or hypertension—qualifies many patients who fall just below the 30 threshold. PlexusDx clinicians assess your individual health profile to determine whether semaglutide fits your specific situation.

Weight-related metabolic dysfunction often accompanies higher BMI values. Insulin resistance, prediabetes, and fatty liver disease are common findings that may strengthen the case for semaglutide therapy. PlexusDx's personalized approach examines your complete metabolic picture, not just your weight, to optimize treatment candidacy and outcomes.

Medication Interactions and Health History Screening

Semaglutide can interact with certain medications, particularly insulin or other blood sugar-lowering agents that may require dose adjustment during treatment. Thyroxine absorption may be affected if semaglutide slows gastric emptying, necessitating timing adjustments. Your PlexusDx clinician reviews all current medications and supplements before prescribing compounded semaglutide to prevent unwanted interactions.

A detailed health history uncovers contraindications and risk factors. Gastroparesis, inflammatory bowel disease, or previous thyroid surgery warrant special consideration. PlexusDx providers document your full medical timeline, surgical history, and family background to design a safe, personalized treatment plan aligned with your health status.

How PlexusDx Simplifies Semaglutide Access Without Insurance

PlexusDx removes insurance barriers by offering compounded semaglutide injections starting at $149 per month, with no membership fees or prior authorization delays. The medication is sourced from licensed 503A compounding pharmacies and shipped directly to your home in all 50 states. HSA and FSA funds are accepted, reducing out-of-pocket costs for eligible patients.

The Precision Peptide Genetic Test—available as a $99 add-on after your first treatment month—identifies your unique genetic predispositions across 14 metabolic pathways, helping PlexusDx clinicians refine your semaglutide protocol. This personalized approach ensures you receive the most effective dose and compound format (injection or oral) matched to your genetic makeup, maximizing weight loss results.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the minimum BMI requirement to qualify for semaglutide at PlexusDx?

PlexusDx clinicians follow the standard guideline: a BMI of 30 or higher, or 27 or higher with weight-related comorbidities such as hypertension or type 2 diabetes. Your provider reviews your individual health profile during the initial assessment to determine eligibility. Many patients qualify even if their BMI sits just below 30, depending on metabolic risk factors.

Can I take semaglutide if I have type 2 diabetes or take insulin?

Yes, semaglutide is often used in diabetes management, but insulin doses may require adjustment during treatment because semaglutide lowers blood sugar. PlexusDx clinicians monitor your glucose levels closely and coordinate with your diabetes care provider to avoid hypoglycemia. Dosing changes are made gradually and supervised to ensure safety.

How much does PlexusDx compounded semaglutide cost compared to branded Ozempic?

PlexusDx compounded semaglutide injections start at $149 per month with no insurance needed, compared to branded Ozempic's typical $1,000+ monthly cost even with insurance. Your dose may need to go up during treatment, but your price won't. No membership fees, no hidden costs—just transparent, affordable access to quality compounded medication.

Are there serious side effects that would disqualify me from semaglutide?

A personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 are absolute contraindications. Severe gastroparesis, acute pancreatitis, or dehydration may also warrant caution. Common side effects include nausea and constipation, which typically diminish over time; PlexusDx provides ongoing support and adjustment strategies to manage these effects.

How does the Precision Peptide Genetic Test improve my semaglutide treatment?

The $99 Precision Peptide Genetic Test maps your GLP-1 receptor, GIPR, FTO, and MC4R genetic variants across 14 metabolic pathways, revealing whether you're a strong, moderate, or less robust responder to GLP-1 therapy. PlexusDx uses these insights to personalize your dose, formulation, and treatment timeline, maximizing your weight loss results. This genetic approach transforms semaglutide from one-size-fits-all to precision medicine.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.